Guangzhou Kingmed has led a $31m series C round for genome sequencing company Yikon Genomics, which was spun out of Harvard University five years ago.

Guangzhou Kingmed has led a $31m series C round for genome sequencing company Yikon Genomics, which was spun out of Harvard University five years ago.

Bayer has led a $25m series B round for Medopad, which allows patients to capture healthcare data through smartphones and watches.

UCSD-founded Shape Therapeutics has collected series A cash from NEA and CureDuchenne Ventures to progress its RNA gene editing technology.

Building on the work of University of Sydney researchers, Kira Biotech has raised $13.6m from investors including IP Group to progress antibodies for autoimmune diseases.

Santander has put a total of $450m into Ebury in a primary and secondary transaction, acquiring a 50.1% stake in the business but maintaining its independence going forward.

Sino Biopharmaceutical has co-led the series D round together with Loyal Valley Capital, while K. Wah Group also contributed.

Merck Global Health Innovation Fund and Bristol-Myers Squibb have provided the final tranche for PathAI’s $75m series B round, adding to an earlier commitment from LabCorp.

Southern Publishing and Media and Cheetah Mobile have contributed to a $57m series C round for edtech developer Codemao.

Goldman Sachs has led a $50m round for credit card provider Deserve, while existing shareholders including Sallie Mae also contributed.